The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies

Journal of the Neurological Sciences

Volumn 152, Issue SUPPL. 1, 1997, Pages

  Gurney, Mark E ^a  

^a PFIZER INC   (United States)

Author keywords

Amyotrophic lateral sclerosis; Riluzole; Superoxide dismutase; Transgenic mice

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; OXYGEN RADICAL; RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SCREENING; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; MOTONEURON; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; SUPEROXIDE DISMUTASE;

EID: 0030690490     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00247-5     Document Type: Conference Paper

References (42)

1. Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.-L., Tarvainnen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genet. 10:1995;61-66.
2. Azzouz M., Leclerc N., Gurney M., Warter J.-M., Poindron P., Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve. 20:1997;45-51.
3. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
4. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis (in collaboration the ALS/Riluzole Study Group). New Engl. J. Med. 330:1994;585-591.
5. Borchelt D.R., Lee M.K., Slunt H.S., Guarnieri M., Xu Z.-S., Wong P.C., Brown R.H., Price D.L., Sisodia S.S., Cleveland D.W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA. 91:1994;8292-8296.
6. Bowling A.C., Schulz J.B., Brown R.H. Jr., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61:1993;2322-2325.
7. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.W., Kwon Y.W., Prattis S.W., Gurney M.E. Age dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6:1995;349-362.
8. Collard J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
9. Cote F., Collard J.F., Julien J.P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell. 73:1993;35-46.
10. Dal Canto M.C., Gurney M.E. The development of CNS pathology in a murine transgenic model of human ALS. Am. J. Pathol. 145:1994;1271-1279.
11. Dal Canto M.C., Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676:1995;25-40.
12. Dal Canto M.C., Gurney M.E. A low expressor line of transgneic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes which most closely resemble those in human ALS. Acta Neuropathol. 93:1997;537-550.
13. Deng H.-X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.-Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Sidddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1993;1047-1051.
14. Duchen L.W., Strich S.J. An hereditary motor neuron disease with progressive denervation of muscle in the mouse: The mutant 'wobbler'. J. Neurol. Neurosurg. Psychiatry. 31:1968;535-547.
15. Getzoff E.D., Cabelli D.E., Fisher C.L., Parge H.E., Viezzoli M.S., Banci L., Hallewell R.A. Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature. 358:1992;347-351.
16. Gurney M.E., Pu H., Chiu A.Y., Dal-Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.-X., Chen W., Zhai P., Sufit R.L., Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
17. Gurney M.E., Cutting F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., Hall E.D. Benefit of Vitamin E, Riluzole, and Gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
18. Hirano A., Kurland L.T., Sayre G.P. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch. Neurol. 16:1967;232-243.
19. Hodgson E.K., Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: Inactivation of the enzyme. Biochemistry. 14:1975;5294-5299.
20. Kostic V., Gurney M.E., Deng H.-X., Siddique T., Epstein C.J., Przedborski S. Midbrain dopaminergic neuronal degeneration in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 41:1997;497-504.
21. Lyons T.J., Liu H., Goto J.J., Nersissian A., Roe J.A., Graden J.A., Cafe C., Ellerby L.M., Bredesen D.E., Gralla E.B., Valentine J.S. Mutations in coper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redoc behavior of the protein. Proc. Natl. Acad. Sci. USA. 93:1996;12240-12244.
22. Messer A., Strominger N.L., Mazurkiewicz J.E. Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouse. J. Neurogenet. 4:1987;201-213.
23. Mitsumoto H., Ikeda K., Klinkosz B., Cedarbaum J.M., Wong V., Lindsay R.M. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science. 265:1994;1107-1110.
24. Mourelatos Z., Gonatas N.K., Stieber A., Gurney M.E., Dal Canto M.C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA. 93:1996;5472-5477.
25. Pelligrini-Giampietro D.E., Cherici G., Alesiani M., Carla V., Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci. 10:1990;1035-1041.
26. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H. Jr., Scott R.W., Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injuy. Nat. Genet. 13:1996;43-47.
27. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 92:1995;689-693.
28. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.-X., Rahamani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Mutations in Cu,Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
29. Sagot Y., Tan S.A., Hammang J.P., Aebischer P., Kato A.C. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16:1996;2335-2341.
30. Schmalbruch H., Jensen H.J., Bjaerg M., Kamieniecka Z., Kurland L. A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol. 50:1991;192-204.
31. Sendtner M., Schmalbruch H., Stockli K.A., Carroll P., Kreutzberg G.W., Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse-mutant progressive motor neuronopathy. Nature. 358:1992;502-504.
32. Siddique T., Deng H.-X. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5:1996;1465-1470.
33. Siddique T., Figlewicz D.A., Pericak-Vance M.A., Haines J.L., Rouleau G., Jeffers A.J., Sapp P., Hung W.Y., Bebout J., McKenna-Yasek D., Deng G., Horvitz H.R., Gusella J.F., Brown R.H., Roses A.D. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic heterogeneity (written with other collaborators). New Engl. J. Med. 324:1991;1381-1384.
34. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M.Y. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 93:1996;3155-3160.
35. Tu P.H., Gurney M.E., Julien J.P., Lee V.M.Y., Trojanowski J.Q. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab. Invest. 76:1997;441-456.
36. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
37. Wokke J. Riluzole. Lancet. 348:1996;795-799.
38. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration og mitochondria. Neuron. 14:1995;1105-1116.
39. Yim M.B., Chock P.B., Stadtman E.R. Copper,zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 87:1990;5006-5010.
40. Yim M.B., Chock P.B., Stadtman E.R. Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J. Biol. Chem. 268:1993;4099-4105.
41. m for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 93:1996;5709-5714.
42. Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:1993;23-33.